Allergan Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia

Allergan, an AbbVie company, announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia. The FDA is expected to act on the NDA by the end of 2021.

Approximately 128 million adults in the U.S. experience presbyopia. Yet, compared to other eye-related conditions, there is a much lower awareness of presbyopia by name.

“Presbyopia is a significant source of frustration for most adults over age 40 who find current treatments inconvenient or invasive,” said Tom Hudson, MD, senior vice president, R&D, chief scientific officer, AbbVie. “If approved, AGN-190584 is expected to be the first eye drop to treat presbyopia, providing a novel option to those affected in the U.S.”

The NDA is based primarily on data from two Phase 3 GEMINI 1 and GEMINI 2 clinical studies, which evaluated the efficacy, safety and tolerability of AGN-190584 (pilocarpine 1.25%). A total of 750 patients were randomized in a one-to-one ratio of vehicle (placebo) to AGN-190584. In both studies, AGN-190584 met the primary endpoint reaching statistical significance in improvement in near vision in mesopic (in low light) conditions without a loss of distance vision vs. the vehicle. There were no treatment emergent serious adverse events observed in any AGN-190584 treated participants. The most common treatment emergent non-serious adverse events occurring at a frequency of ≥5% in AGN-190584 treated participants were headache and conjunctival hyperemia.

Click HERE for the full press release.

Featured Posts

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Learn More
Alcon

Alcon Completes Acquisition of Aerie Pharmaceuticals

Alcon announced that it has completed its acquisition of Aerie Pharmaceuticals (Aerie).

Read more

B + L Reports More Than 58 Million Units of CL Materials Collected Through Recycling Programs

Bausch + Lomb announced its unique ONE by ONE and Biotrue Eye Care Recycling programs have collected a total of 58,677,480 million units, or 356,723 pounds, of used contact lens, eye care and lens care materials, which is equivalent to the weight of 108 midsize vehicles.

Read more

iA Financial Group Philanthropic Contest: CNIB in the Running to Win a Donation of $100,000

The Canada-wide philanthropic contest awards a donation of $100,000 to the four charities that receive the most votes. The remaining eight charities will each receive $10,000. 

Read more

Woodys: Far from Mainstream

Woodys! Born to break with the mainstream and depict a world full of unique stories and characters.

Read more

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Learn More
Alcon

Alcon Completes Acquisition of Aerie Pharmaceuticals

Alcon announced that it has completed its acquisition of Aerie Pharmaceuticals (Aerie).

Read More

B + L Reports More Than 58 Million Units of CL Materials Collected Through Recycling Programs

Bausch + Lomb announced its unique ONE by ONE and Biotrue Eye Care Recycling programs have collected a total of 58,677,480 million units, or 356,723 pounds, of used contact lens, eye care and lens care materials, which is equivalent to the weight of 108 midsize vehicles.

Read More

iA Financial Group Philanthropic Contest: CNIB in the Running to Win a Donation of $100,000

The Canada-wide philanthropic contest awards a donation of $100,000 to the four charities that receive the most votes. The remaining eight charities will each receive $10,000. 

Read More

Woodys: Far from Mainstream

Woodys! Born to break with the mainstream and depict a world full of unique stories and characters.

Read More

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Learn More
Alcon

Alcon Completes Acquisition of Aerie Pharmaceuticals

Alcon announced that it has completed its acquisition of Aerie Pharmaceuticals (Aerie).

Read more

B + L Reports More Than 58 Million Units of CL Materials Collected Through Recycling Programs

Bausch + Lomb announced its unique ONE by ONE and Biotrue Eye Care Recycling programs have collected a total of 58,677,480 million units, or 356,723 pounds, of used contact lens, eye care and lens care materials, which is equivalent to the weight of 108 midsize vehicles.

Read more

iA Financial Group Philanthropic Contest: CNIB in the Running to Win a Donation of $100,000

The Canada-wide philanthropic contest awards a donation of $100,000 to the four charities that receive the most votes. The remaining eight charities will each receive $10,000. 

Read more

Woodys: Far from Mainstream

Woodys! Born to break with the mainstream and depict a world full of unique stories and characters.

Read more

Brunello Cucinelli and EssilorLuxottica, Together for the Next Ten Years

The Solomeo Casa di Moda and EssilorLuxottica signed an exclusive license agreement that will strengthen their partnership

Learn More
Alcon

Alcon Completes Acquisition of Aerie Pharmaceuticals

Alcon announced that it has completed its acquisition of Aerie Pharmaceuticals (Aerie).

Read more

B + L Reports More Than 58 Million Units of CL Materials Collected Through Recycling Programs

Bausch + Lomb announced its unique ONE by ONE and Biotrue Eye Care Recycling programs have collected a total of 58,677,480 million units, or 356,723 pounds, of used contact lens, eye care and lens care materials, which is equivalent to the weight of 108 midsize vehicles.

Read more

iA Financial Group Philanthropic Contest: CNIB in the Running to Win a Donation of $100,000

The Canada-wide philanthropic contest awards a donation of $100,000 to the four charities that receive the most votes. The remaining eight charities will each receive $10,000. 

Read more

Woodys: Far from Mainstream

Woodys! Born to break with the mainstream and depict a world full of unique stories and characters.

Read more